# Maternal-Fetal Medicine Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mumtaz Mahal (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE006-SYN
- Date: 2026-01-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Farzana Qureshi-Lindholm, MD
- Calendar frame: modern shifted

- To: Adaeze Montgomery-Rahimi, MD, Maternal-Fetal Medicine
- Urgency: Routine, within four weeks

## Referral question

Fourteenth pregnancy at 37, at 13 weeks 2 days by today's scan, conceived about five and a half months after her last birth, with iron deficiency anemia. Please advise on surveillance, anemia treatment, placental assessment, the timing and place of birth, and planning to prevent postpartum hemorrhage. **S**

## Questions for the consultant

1. What surveillance does this pregnancy need, given her age, grand multiparity, and the short interval since her last birth?
2. How should her iron deficiency anemia be treated, and when should we move to intravenous iron?
3. How should the placenta be assessed for previa and accreta after thirteen births?
4. When and where should she give birth, and should labor be induced?
5. What should the postpartum hemorrhage prevention and treatment plan include?
6. What advice should she have about travel during this pregnancy?
7. When and how should contraception and the interval before any future pregnancy be discussed?

## Pertinent history

Mumtaz Mahal is a 37-year-old woman, gravida 14 para 13, with thirteen previous vaginal births and no cesarean or other uterine surgery; seven of her children are living. Her last baby was born nine months ago; she breastfed for five months and her periods had not returned, so today's scan is used for dating: single live intrauterine pregnancy, crown-rump length 72 mm (13 weeks 2 days), nuchal translucency 1.7 mm. She is tired and breathless on stairs. Hemoglobin 10.1 g/dL, MCV 76 fL, ferritin 9 ng/mL, platelets 245; hemoglobin electrophoresis sent. Hemoglobin A1c 5.4 percent (early screen: South Asian heritage and BMI 23.8). Blood pressure 104/64 mmHg. Height 157 cm, weight 58.6 kg. She starts ferrous sulfate every other day, aspirin 81 mg at bedtime (age 35 or older and a previous adverse pregnancy outcome), and folic acid today, and chose cell-free DNA screening, drawn today. She had the influenza vaccine today. EPDS 8. She travels often with her family for long periods. No medical history, medicines, or allergies otherwise. **S**

- She was born Arjumand Banu Begum in Agra in April 1593; an encyclopedia, citing a seventeenth-century court history, gives 27 April 1593. **D**
- Her father, Abu'l-Hasan Asaf Khan, was a Persian noble; his sister was the Empress Nur Jahan, wife of the emperor Jahangir. Her mother's family came from Qazvin in Persia. **D**
- She was betrothed to Prince Khurram, later the emperor Shah Jahan, in 1607, and married him on 10 May 1612; he gave her the title Mumtaz Mahal, rendered as 'Chosen One of the Palace' or 'the Exalted One of the Palace'. **D**
- She was a Shi'a Muslim. **D**
- Despite her frequent pregnancies, she travelled with her husband's entourage on his military campaigns. **D**
- Her first thirteen children were born between 1613 and 1630: Hur-ul-Nisa (1613), Jahanara (1614), Dara Shikoh (1615), Shah Shuja (1616), Roshanara (1617), Aurangzeb (1618), Izad Bakhsh (1619), Surayya Banu (1621), a son who died soon after birth (1622), Murad Bakhsh (1624), Lutf Allah (1626), Daulat Afza (1628), and Husn Ara (1630). **D**
- Six of her children died in infancy or early childhood before 1631: Hur-ul-Nisa at three and Surayya Banu at seven, both of smallpox; Izad Bakhsh in infancy; a son soon after birth in 1622; Lutf Allah at about eighteen months; and Daulat Afza in infancy. **D**
- Her thirteenth child, Husn Ara, was born on 23 April 1630. **D**
- In the year 1040 AH (from August 1630) the emperor was in the Deccan with the court at Burhanpur, during a severe famine in the Deccan and Gujarat, when he ordered soup kitchens and weekly alms for as long as he remained at Burhanpur. **D**

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 10.1 g/dL (low); MCV: 76 fL (low); White blood cells: 8.6 10*3/uL; Platelets: 245 10*3/uL; Ferritin: 9 ng/mL (low); Hemoglobin A1c: 5.4%; Crown-rump length: 72 mm; Nuchal translucency: 1.7 mm; EPDS: 8. All results are synthetic.

BP 104/64 mmHg; pulse 84 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 58.6 kg; BMI 23.8 kg/m². All vital signs are synthetic.

## Current medications

- Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day **S**
- Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime **S**

## Plan so far

- First prenatal visit: dating and nuchal translucency scan; blood count, ferritin, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture for asymptomatic bacteriuria; hemoglobin electrophoresis for microcytosis; hemoglobin A1c as an early diabetes screen; influenza vaccine; folic acid. Guideline: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); USPSTF A and B Recommendations (2026); Guidelines for Vaccinating Pregnant Persons (2026) **S**
- Aneuploidy screening offered, with diagnostic testing available: cell-free DNA and the nuchal translucency measurement today, or chorionic villus sampling or amniocentesis; she chose cell-free DNA. Guideline: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020) **S**
- Iron deficiency anemia: ferrous sulfate 325 mg every other day; repeat blood count and ferritin in four weeks, with intravenous iron in the second trimester if she cannot tolerate oral iron or the hemoglobin does not rise; aim for hemoglobin of 11 g/dL or more before delivery. Guideline: Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021) **S**
- Preeclampsia prevention: aspirin 81 mg at bedtime from 13 weeks until delivery for two moderate risk factors (age 35 or older and a previous adverse pregnancy outcome); blood pressure and urine protein at every visit. Guideline: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021) **S**
- Detailed anatomy scan at 20 to 22 weeks with placental location; if the placenta is low-lying or covers the cervix, a repeat scan at 32 weeks and assessment for placenta accreta spectrum. Guideline: Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11 (2022); Obstetric Care Consensus No. 7: Placenta Accreta Spectrum (2018) **S**
- Gestational diabetes: hemoglobin A1c today because she is of South Asian heritage with a BMI of 23 or more; one-hour glucose challenge at 24 to 28 weeks. Guideline: ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus (2018) **S**
- Travel: travel is reasonable until about 36 weeks if the pregnancy stays uncomplicated; on long journeys walk every one to two hours, drink plenty, and wear compression stockings; carry her prenatal record; find maternity care where she stays; stay near the delivery hospital from 36 weeks. Guideline: ACOG Committee Opinion No. 746: Air Travel During Pregnancy (2018) **S**
- Postpartum hemorrhage risk assessment at intake and again in the third trimester and on admission for birth (grand multiparity and anemia raise her risk); delivery planned in a hospital with a blood bank, anesthesia, and an operating theatre. Guideline: Practice Bulletin No. 183: Postpartum Hemorrhage (2017); WHO recommendations for the prevention and treatment of postpartum haemorrhage (2012) **S**
- Mood: EPDS in each trimester, with support for the grief of having lost several children. Guideline: Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023) **S**
